Novartis AG is 185.8x more valuable than Sionna Therapeutics, Inc. by market capitalization ($283.13 B vs $1.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SION | NVS |
|---|---|---|
| Market cap | $1.52 B | $283.13 B |
| US-listed rank | #2311 | #47 |
| Net income (latest FY) | -$75.27M | - |
| SEC filings | 200 | 947 |
Novartis AG is 185.8x more valuable than Sionna Therapeutics, Inc. by market capitalization ($283.13 B vs $1.52 B).
Full pages: Sionna Therapeutics, Inc. and Novartis AG, or browse the full rankings.